Latest News and Press Releases

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aligos to receive an upfront payment of $25M USDUp to $420M USD in clinical, regulatory, and sales milestones along with tiered, high single-digit royaltiesAmoytop to fund its development program in...

Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

BERLIN und MÜNCHEN, Deutschland, April 16, 2026 (GLOBE NEWSWIRE) -- Die ATOSS Software SE, führender Anbieter digitaler Workforce Management Lösungen, wird der Charité – Universitätsmedizin...

BASEL, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated...

Washington, DC, April 15, 2026 (GLOBE NEWSWIRE) -- The Association for Frontotemporal Degeneration (AFTD) hosted its first Capitol Hill briefing, Frontotemporal Degeneration: Shining a Light on a...

Elion Therapeutics initiated a Phase 2 study of turletricin in invasive mould infection ("TREAT-1") and is presenting early clinical data at ESCMID 2026.

Washington, DC, April 15, 2026 (GLOBE NEWSWIRE) -- The Association for Frontotemporal Degeneration (AFTD) hosted its first Capitol Hill briefing, Frontotemporal Degeneration: Shining a Light on a...

Riyadh, Saudi Arabia, April 15, 2026 (GLOBE NEWSWIRE) -- On the evening of April 15, HRH Prince Turki Alfaisal, Acting Chairman of the Board of Trustees of King Faisal Foundation, and King Faisal...

Shingles isn’t just a painful rash and nerve pain. It’s also linked with a higher risk of serious cardiovascular events, including heart attack and stroke.